Ashby Michael T, Kreth Jens, Soundarajan Muthu, Sivuilu Laure Sita
Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Microbiology (Reading). 2009 Nov;155(Pt 11):3691-3700. doi: 10.1099/mic.0.031310-0. Epub 2009 Aug 14.
Streptococcus is a dominant genus in the human oral cavity, making up about 20 % of the more than 800 species of bacteria that have been identified, and about 80 % of the early biofilm colonizers. Oral streptococci include both health-compatible (e.g. Streptococcus gordonii and Streptococcus sanguinis) and pathogenic strains (e.g. the cariogenic Streptococcus mutans). Because the streptococci have similar metabolic requirements, they have developed defence strategies that lead to antagonism (also known as bacterial interference). S. mutans expresses bacteriocins that are cytotoxic toward S. gordonii and S. sanguinis, whereas S. gordonii and S. sanguinis differentially produce H(2)O(2) (under aerobic growth conditions), which is relatively toxic toward S. mutans. Superimposed on the inter-bacterial combat are the effects of the host defensive mechanisms. We report here on the multifarious effects of bovine lactoperoxidase (bLPO) on the antagonism between S. gordonii and S. sanguinis versus S. mutans. Some of the effects are apparently counterproductive with respect to maintaining a health-compatible population of streptococci. For example, the bLPO system (comprised of bLPO+SCN(-)+H(2)O(2)) destroys H(2)O(2), thereby abolishing the ability of S. gordonii and S. sanguinis to inhibit the growth of S. mutans. Furthermore, bLPO protein (with or without its substrate) inhibits bacterial growth in a biofilm assay, but sucrose negates the inhibitory effects of the bLPO protein, thereby facilitating adherence of S. mutans in lieu of S. gordonii and S. sanguinis. Our findings may be relevant to environmental pressures that select early supragingival colonizers.
链球菌是人类口腔中的优势菌属,在已鉴定出的800多种细菌中约占20%,在早期生物膜定植菌中约占80%。口腔链球菌包括与健康相容的菌株(如戈登链球菌和血链球菌)和致病菌株(如致龋变形链球菌)。由于链球菌具有相似的代谢需求,它们发展出了导致拮抗作用(也称为细菌干扰)的防御策略。变形链球菌表达对戈登链球菌和血链球菌具有细胞毒性的细菌素,而戈登链球菌和血链球菌在有氧生长条件下会分别产生对变形链球菌相对有毒的过氧化氢。宿主防御机制的作用叠加在细菌间的对抗之上。我们在此报告牛乳铁过氧化物酶(bLPO)对戈登链球菌和血链球菌与变形链球菌之间拮抗作用的多种影响。其中一些影响在维持与健康相容的链球菌群体方面显然适得其反。例如,bLPO系统(由bLPO + SCN(-)+H2O2组成)会破坏过氧化氢,从而消除戈登链球菌和血链球菌抑制变形链球菌生长的能力。此外,bLPO蛋白(无论有无底物)在生物膜试验中都会抑制细菌生长,但蔗糖会抵消bLPO蛋白的抑制作用,从而促进变形链球菌取代戈登链球菌和血链球菌的黏附。我们的发现可能与选择早期龈上定植菌的环境压力有关。